These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1056 related articles for article (PubMed ID: 30267647)
21. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical localization of spatacsin in α-synucleinopathies. Kuru S; Yoshida M; Tatsumi S; Mimuro M Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408 [TBL] [Abstract][Full Text] [Related]
23. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies. Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200 [TBL] [Abstract][Full Text] [Related]
24. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Patterson L; Rushton SP; Attems J; Thomas AJ; Morris CM Brain Pathol; 2019 Jul; 29(4):544-557. PubMed ID: 30582885 [TBL] [Abstract][Full Text] [Related]
25. Expanding the spectrum of neuronal pathology in multiple system atrophy. Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961 [TBL] [Abstract][Full Text] [Related]
26. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra. Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370 [TBL] [Abstract][Full Text] [Related]
27. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718 [TBL] [Abstract][Full Text] [Related]
28. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
29. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247 [TBL] [Abstract][Full Text] [Related]
30. Involvement of autophagic protein DEF8 in Lewy bodies. Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708 [TBL] [Abstract][Full Text] [Related]
31. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352 [TBL] [Abstract][Full Text] [Related]
32. Neuropathology and molecular diagnosis of Synucleinopathies. Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583 [TBL] [Abstract][Full Text] [Related]
34. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy. Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891 [TBL] [Abstract][Full Text] [Related]
35. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy. Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991 [TBL] [Abstract][Full Text] [Related]
36. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Hishikawa N; Hashizume Y; Yoshida M; Sobue G Neuropathol Appl Neurobiol; 2001 Oct; 27(5):362-72. PubMed ID: 11679088 [TBL] [Abstract][Full Text] [Related]